Examples of using Decrease in haemoglobin in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Anaemia(decrease in haemoglobin)a, b.
TIMI Minor: Clinically apparent with 30-50 g/L decrease in haemoglobin.
Decrease in haemoglobin and in haematocrit.
That treatment with STAYVEER is associated with a decrease in haemoglobin.
Decrease in haemoglobin in your blood low red blood cell count.
Clinically apparent with 30 50 g/l decrease in haemoglobin.
G/dL decrease in haemoglobin during any 4-week treatment period.
That treatment with Volibris often causes a decrease in haemoglobin and haematocrit.
Decrease in haemoglobin, Decrease in haematocrit, Neutropenia, Thrombocytopenia.
None of these changes were associated with bleeding episodes or a decrease in haemoglobin.
That STAYVEER causes a decrease in haemoglobin and the need for regular blood tests.
The need for regular blood tests because Opsumit causes a decrease in haemoglobin;
Decrease in haemoglobin(oxygen-carrying pigment in blood)
50 g/L decrease in haemoglobin or intracranial haemorrhage.
Decrease in haemoglobin in your blood increased fatty acids(triglycerides),
50 g/L decrease in haemoglobin or intracranial haemorrhage.
A decrease in haemoglobin, which was not clinically significant,
That treatment with Thelin often causes a decrease in haemoglobin and related red cell parameters.
clinically apparent with> 50 g/L decrease in haemoglobin or≥4 red cell units transfused.
Major Other: Clinically apparent with 30 50 g/L decrease in haemoglobin or 2-3 red cell units transfused;
Decrease in haemoglobin, decrease in haematocrit,
Macitentan may lead to more reduction of blood pressure and decrease in haemoglobin in patients with kidney problems.
defined by a decrease in haemoglobin(1-2 g/ dl per month)
clinically apparent with 30-50 g/L decrease in haemoglobin, OR 2-3 red cell units transfused.
That treatment with Thelin often causes a decrease in haemoglobin and related red cell parameters o Need for full blood count prior to use and monitoring at clinically appropriate intervals.
That treatment with Volibris often causes a decrease in haemoglobin and haematocrit o Initiation of Volibris is not recommended for patients with clinically significant anaemia. o Patients taking Volibris should have their haemoglobin and/or haematocrit levels measured regularly. o If tests show a clinically significant decrease in haemoglobin or haematocrit, and other causes have been excluded,
50 g/l decrease in haemoglobin or≥4 red cell units transfused; or fatal; or intracranial;
Decreases in haemoglobin, neutrophils and platelets may require dose reduction
Decreases in haemoglobin and haematocrit, thrombocytopenia, leucopenia/ neutropenia, and cases of agranulocytosis